Benzinga | Jul 27, 2020 11:42AM EDT

JMP Securities Upgrades Enanta Pharmaceuticals to Market Outperform, Announces $70 Price Target

JMP Securities upgrades Enanta Pharmaceuticals (NASDAQ:ENTA) from Market Perform to Market Outperform and announces $70 price target.